To include your compound in the COVID-19 Resource Center, submit it here.

Researchers identify new targets for DMD

Two studies published in Nature Communications show that decreasing expression of nuclear factor I X (NFIX) or sarcolipin (SLN) improves phenotypes associated with Duchenne muscular dystrophy in mouse models of the disease, identifying new targets for the indication.

In one study, researchers

Read the full 418 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers